| Product Code: ETC9417533 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea mRNA Vaccine and Therapeutics Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 South Korea mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 South Korea mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and funding for mRNA vaccine research and development |
4.2.2 Growing prevalence of infectious diseases and chronic conditions driving the demand for innovative therapeutics |
4.2.3 Technological advancements in mRNA technology leading to improved efficacy and safety of vaccines and therapeutics |
4.3 Market Restraints |
4.3.1 Regulatory challenges and approval processes for mRNA vaccines and therapeutics |
4.3.2 High cost of development and production of mRNA vaccines compared to traditional vaccines |
4.3.3 Limited manufacturing capacity and distribution challenges for mRNA vaccines and therapeutics |
5 South Korea mRNA Vaccine and Therapeutics Market Trends |
6 South Korea mRNA Vaccine and Therapeutics Market, By Types |
6.1 South Korea mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 South Korea mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 South Korea mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 South Korea mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 South Korea mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 South Korea mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 South Korea mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 South Korea mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research and development investment in mRNA technology |
8.2 Clinical trial success rates for mRNA vaccines and therapeutics |
8.3 Adoption rate of mRNA vaccines in the healthcare system |
9 South Korea mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 South Korea mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 South Korea mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 South Korea mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 South Korea mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 South Korea mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 South Korea mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 South Korea mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here